<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01718886</url>
  </required_header>
  <id_info>
    <org_study_id>PTL-1000-0018</org_study_id>
    <nct_id>NCT01718886</nct_id>
  </id_info>
  <brief_title>European Study to Evaluate Preliminary Safety and Efficacy of Multiple Obalon Gastric Balloons for 12 Weeks as an Aid for Weight Loss</brief_title>
  <official_title>Feasibility Study to Evaluate Preliminary Safety and Efficacy of Multiple Obalon Gastric Balloons for 12 Weeks as an Aid for Weight Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Obalon Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Obalon Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the initial safety and preliminary effectiveness
      of the Obalon intragastric balloon system in European subjects with a BMI in the range of 27
      - 35 kg/m^2
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Excess Weight Loss based on an ideal BMI of 25.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of all adverse events.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">17</enrollment>
  <condition>Obesity</condition>
  <condition>Weight Control</condition>
  <arm_group>
    <arm_group_label>Obalon Gastric Balloon</arm_group_label>
    <description>Patients received 1-3 Obalon Gastric Balloons over a period of 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Obalon Gastric Balloon</intervention_name>
    <arm_group_label>Obalon Gastric Balloon</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients were selected from investigators' patient population and included patients with a
        BMI in the range of 27 - 35 kg/m^2
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Were between 21-64 years of age;

          -  Had a BMI 27-35 Kg/cm

          -  Did not have a history of weight reduction over 5% of body weight over the past 6
             months

          -  Were able to comply with all study requirements for the duration of the study as
             outlined in the protocol. This included complying with the visit schedule as well as
             study specific procedures such as: electrocardiography, endoscopy, upper
             gastrointestinal radiography and clinical lab testing

          -  Were able to understand and willing to provide written informed consent

        Exclusion Criteria:

          -  Experienced any difficulty in swallowing;

          -  Had unstable angina, myocardial infarction within the past year, or heart disease
             classified within the New York Heart Association's Class III or IV functional
             capacity;

          -  Taking chronic aspirin or other non steroidal anti-inflammatory agents, or other
             medications known to be gastric irritants, and not willingness to discontinue the use
             of these concomitant medications, antiarrythmics, anti-anginal medications,
             anticoagulants or medications for congestive heart failure;

          -  Taking blood pressure medications, unless their blood pressure was controlled and they
             have been at stable dose for at least 3 months;

          -  Had type 1 diabetes or Type 2 diabetes requiring oral medications or insulin;

          -  Had a history or symptoms of thyroid disease which is not controlled by medication;

          -  Had severe renal, hepatic, pulmonary disease or cancer;

          -  Had past history of gastrointestinal surgery (excluding uncomplicated appendectomy);

          -  Had any abnormal stenosis or obstruction of the GI tract;

          -  Had a history of adhesive peritonitis;

          -  Had a previously diagnosed hiatal hernia greater than 2cm;

          -  Had any abnormality of the esophagus, stomach or pylorus;

          -  Had history of severe esophagitis;

          -  Had history or symptoms of esophageal and/or gastric varices;

          -  Had history or congenital or acquired GI anomalies (e.g. atresias, stricture, and /or
             diverticula);

          -  Had history or symptoms of inflammatory bowel disease, such as Chron's disease;

          -  Had history of/ signs and /or symptoms of duodenal or gastric ulcer;

          -  Untreated H.Pylori

          -  Had history or signs of dysphasia, achalasia or symptoms of or GI motility;

          -  Were undergoing chronic steroid or immunosuppressive therapy;

          -  Were pregnant or breastfeeding or had the intention of becoming pregnant during the
             study;

          -  Had placement of previous intragastric balloon or similar device;

          -  Were using pharmaceutical agents for weight loss;

          -  Were drinking alcohol in excess or using illicit drugs;

          -  Had bulimia or binge eating disorders;

          -  Had impending gastric surgery 30 days post balloon removal;

          -  Had planned flying or scuba diving activities during balloon residence time;

          -  Had any other condition that, in the opinion of the investigator, would interfere with
             their participation and compliance with the study (i.e. psychosocial issues);

          -  Were participating in other investigational study protocols. If a subject had recently
             completed participation in another drug or device study, the subject must have
             completed that study at least 30 days prior to being enrolled in this study;

          -  Had history or known allergies to any component of the device materials, including but
             not limited to allergies to porcine proteins.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fancois Mion, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Edouard Harriot</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacques Deviere</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasme Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Gastroenterology, Erasme Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>6B1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service D'exploration Functionelle Digestive, Hospital Edouard Harriot</name>
      <address>
        <city>Lyon</city>
        <state>Cedex</state>
        <zip>69473</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.obalon.com</url>
    <description>Sponsor's website</description>
  </link>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2012</study_first_submitted>
  <study_first_submitted_qc>October 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2012</study_first_posted>
  <last_update_submitted>October 29, 2012</last_update_submitted>
  <last_update_submitted_qc>October 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Weight loss</keyword>
  <keyword>Weight control</keyword>
  <keyword>Intragastric balloon</keyword>
  <keyword>gastric balloon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

